lobbying_activities: 2112485

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2112485	5ecd9341-5e3b-40d7-89bd-c61fc10c2e40	Q1	ARENTFOX SCHIFF LLP	4208	KEMPHARM, INC.	2018	first_quarter	PHA	FDA regulation of opioid abuse deterrent formulations	HOUSE OF REPRESENTATIVES,SENATE,White House Office	30000		0	0	2018-04-18T23:38:18.590000-04:00